Ultragenyx Pharmaceutical (RARE) Stock Price & Financial Analysis
Ultragenyx Pharmaceutical Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Ultragenyx Pharmaceutical
What is the current stock price for RARE?
As of the latest trading session, RARE stock trades at $22.45. The 52-week range is $18.29–$42.37, with a day range of $20.79–$22.45.
What is the P/E ratio for RARE?
The P/E ratio (Price-to-Earnings) for RARE is shown in the Key Statistics section. This valuation metric helps compare Ultragenyx Pharmaceutical Inc. to industry peers.
Does RARE pay dividends?
Ultragenyx Pharmaceutical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RARE?
Based on 7 analysts, the consensus for RARE is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RARE?
Ultragenyx Pharmaceutical's market capitalization is $2.21B, classifying it as a mid-cap company. Ultragenyx Pharmaceutical operates in the Healthcare sector within the Biotechnology industry.